Short Interest in AirSculpt Technologies, Inc. (NASDAQ:AIRS) Expands By 18.0%

AirSculpt Technologies, Inc. (NASDAQ:AIRS) saw a significant increase in short interest in December. As of December 31st, there was short interest totalling 2,690,000 shares, an increase of 18.0% from the December 15th total of 2,280,000 shares. Approximately 21.6% of the company’s shares are sold short. Based on an average daily trading volume, of 217,100 shares, the short-interest ratio is currently 12.4 days.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the stock. Piper Sandler reduced their price target on shares of AirSculpt Technologies from $6.00 to $5.00 and set a “neutral” rating on the stock in a research report on Friday. BTIG Research assumed coverage on shares of AirSculpt Technologies in a report on Thursday, October 17th. They issued a “neutral” rating on the stock. Five analysts have rated the stock with a hold rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $5.00.

AirSculpt Technologies Price Performance

Shares of AIRS opened at $5.33 on Friday. AirSculpt Technologies has a 52-week low of $2.92 and a 52-week high of $9.20. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.51 and a current ratio of 0.51. The business has a fifty day moving average of $6.16 and a 200 day moving average of $5.27.

AirSculpt Technologies (NASDAQ:AIRS) last posted its quarterly earnings data on Friday, November 8th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.05). The company had revenue of $42.55 million for the quarter, compared to analyst estimates of $42.49 million. AirSculpt Technologies had a negative net margin of 4.13% and a positive return on equity of 2.22%. During the same quarter last year, the company earned ($0.01) EPS. On average, research analysts predict that AirSculpt Technologies will post 0.01 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CEO Dennis Dean sold 24,510 shares of the company’s stock in a transaction on Friday, November 15th. The stock was sold at an average price of $6.54, for a total transaction of $160,295.40. Following the completion of the sale, the chief executive officer now owns 582,052 shares in the company, valued at approximately $3,806,620.08. This represents a 4.04 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 78.30% of the stock is owned by insiders.

Hedge Funds Weigh In On AirSculpt Technologies

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Barclays PLC increased its holdings in shares of AirSculpt Technologies by 227.0% during the 3rd quarter. Barclays PLC now owns 19,100 shares of the company’s stock valued at $97,000 after purchasing an additional 13,259 shares in the last quarter. Geode Capital Management LLC grew its position in AirSculpt Technologies by 6.4% during the third quarter. Geode Capital Management LLC now owns 355,540 shares of the company’s stock valued at $1,803,000 after buying an additional 21,339 shares during the period. Finally, SW Investment Management LLC grew its position in AirSculpt Technologies by 5.0% during the second quarter. SW Investment Management LLC now owns 4,500,000 shares of the company’s stock valued at $18,000,000 after buying an additional 213,677 shares during the period. Hedge funds and other institutional investors own 91.54% of the company’s stock.

AirSculpt Technologies Company Profile

AirSculpt Technologies, Inc, together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure.